Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Data supporting the use of Tocilizumab (TCZ) in COVID-19 are contrasting and inconclusive. This meta-analysis aimed to assess TCZ effectiveness in reducing the mortality rate in COVID-19 patients. PubMed, Scopus, Embase, Cochrane, WILEY, and ClinicalTrials.gov were searched to evaluate observational...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pers Med
Main Authors: Conti, Valeria, Corbi, Graziamaria, Sellitto, Carmine, Sabbatino, Francesco, Maci, Chiara, Bertini, Nicola, De Bellis, Emanuela, Iuliano, Antonio, Davinelli, Sergio, Pagliano, Pasquale, Filippelli, Amelia
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307114/
https://ncbi.nlm.nih.gov/pubmed/34357095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070628
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki